FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns medicine, particularly immunotherapy. Invention claims bispecific antibody and its application in tumour treatment. New antibody can link to EGF receptor and includes two antigene-binding sites linking to different epitopes of indicated receptor, thus ensuring higher receptor engagement by antibodies at the same dosage. It allows for higher antibody density on receptor and significant inhibition of tumour growth and/or enhancement of solid tumour or metastasis apoptosis.
EFFECT: higher receptor engagement by antibodies at the same dosage.
16 cl, 2 ex
| Title |
Year |
Author |
Number |
| PHARMACEUTICAL COMPOSITIONS AIMED AT Erb-B1 RECEPTORS |
2003 |
- Krejsh Khans-Georg
- Shmidt Jurgen
|
RU2354402C2 |
| COMBINED THERAPY USING INHIBITORS OF TYROSINE KINASE RECEPTORS AND INHIBITORS OF ANGIOGENESIS |
2001 |
- Gudman Sajmon
- Krejsh Khans-Georg
|
RU2292904C2 |
| COMBINED THERAPY BY USING ANTIANGIOGENIC AGENTS AND TNF-ALPHA |
2002 |
- Grell' Mattias
- Gudman Sajmon
- Rjugg Kurtsio
|
RU2316337C2 |
| HUMANIZED ANTIBODY THAT SHOWS CAPACITY TO BIND ErbB2 AND BLOCK ACTIVATION OF ErbB2 RECEPTOR BY LIGAND (VARIANTS) AND COMPOSITION FOR USING IN CANCER TREATMENT COMPRISING THIS ANTIBODY |
2000 |
- Adams Kamellia U.
- Presta Lenard G.
- Slivkovski Mark
|
RU2270029C2 |
| HIGH-AFFINITY ANTI-CD3 ANTIBODIES AND METHODS FOR PRODUCTION AND USE THEREOF |
2020 |
- Pejchal, Robert
- Stein, Caitlin
- Mccreary, Julia
|
RU2831840C2 |
| MEANS OF IDENTIFICATION OF TUMOURS, ACQUISITIVE TO TREATMENT BY ANTIBODIES AGAINST ErbB2 |
2003 |
- Koll' Khans
- Bossenmajer Birgit
- Mjuller Khans-Joakhim
- Slivkovski Mark K.
- Kelsi Stefen Majkl
|
RU2338751C2 |
| THERAPY OF MALIGNANT TUMOR, RESISTANT TO PLATINUM-BASED MEDICATIONS |
2005 |
|
RU2403065C2 |
| COMPOSITION CONTAINING ANTIBODY BINDING TO DOMAIN II OF HER2, AND ITS ACIDIC VERSIONS |
2009 |
- Kharris, Rid, Dzh.
- Motchnik, Pol, A.
|
RU2543664C2 |
| BISPECIFIC BINDING AGENTS FOR MODULATING BIOLOGICAL ACTIVITY |
2005 |
- Nilsen Ulrik B.
- Shoehberl' Birgit M.
|
RU2433831C2 |
| MODIFIED ANTI-EGFR ANTIBODIES WITH REDUCED AMMONOGENICITY |
2002 |
- Karr Frehnsis Dzh.
- Karter Grehm
- Dzhons Tim
- Uill'Jams Stiven
- Khamil'Ton Anita
|
RU2297245C2 |
